Glenn Paradis, BA, CFAGuidant CorpGDTDON'T BUYJan 02, 2003

One of their large sectors is in stents, but they are not drug coated. Has a lot of competition.

Glenn Paradis, BA, CFA

Unknown

Unlock Rating

$31.60

Stock price when the opinion was issued

biotechnologypharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

DON'T BUY

Boston Scientific (BSX-N) is trying to buy. If you buy this stock, you are hoping that J&J (JNJ-N) will come with a higher bid which they might. This would be a trade rather than a long-term investment.

Most Recent Experts

Malcolm Ethridge, Mgn. partner, Capital Area Planning Group

Capital Area Planning Group

Kevin Simpson

Capital Wealth Planning

Josh Brown, CEO, Ritholtz Wealth Management

Ritholtz Wealth Management

Michael Hakes - CFA, MBA

Murray Wealth Group

Stephanie Link, Chief investment strategist, Hightower

Hightower

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Glenn Paradis, BA, CFAGuidant CorpGDTDON'T BUYJan 02, 2003

You might be interested:

Guidant Corp(GDT)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals